Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study)

Published:2013-01-24 Issue:1 Volume:13 Page:47-56
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Park Jeong Bae,Sung Ki-Chul,Kang Seok-Min,Cho Eun Joo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s40256-013-0004-9/fulltext.html

Reference33 articles.

1. Wassmann S, Nickenig G. The role of the AT1 receptor in the cardiovascular continuum. Eur Heart J. 2004;6(Suppl H):H3–9.

2. Aulakh GK, Sodhi RK, Singh M. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators. Life Sci. 2007;81(8):615–39.

3. Gavras H, Flessas A, Ryan TJ, et al. Angiotensin II inhibition: treatment of congestive cardiac failure in a high-renin hypertension. JAMA. 1977;238:880–92.

4. Choi DJ, Han S, Jeon ES, et al. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the Korean heart failure registry. Korean Circ J. 2011;41(7):363–71.

5. Sawada T, Yamada H, Dahlöf B, et al. on Kyoto Heart Study Group. Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: Kyoto Heart Study. Eur Heart J. 2009;30(20):2461–9.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signal detection statistics of adverse drug events in hierarchical structure for matched case–control data;Biostatistics;2023-10-26

2. Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction;Journal of Korean Medical Science;2023

3. Simultaneous Analysis of a Combination of Anti-Hypertensive Drugs, Fimasartan, Amlodipine, and Hydrochlorothiazide, in Rats Using LC-MS/MS and Subsequent Application to Pharmacokinetic Drug Interaction with Red Ginseng Extract;Toxics;2022-09-30

4. Newer Angiotensin Receptor Blockers;Hypertension and Cardiovascular Disease in Asia;2022

5. Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study;Journal of Clinical Neurology;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3